Companies such as Syrah Resources and Medical Developments International have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance their portfolio should consider these financially stable, high-growth stocks. Below I’ve put together a list of great potential investments for you to consider adding to your portfolio if growth is a dimension you would like to firm up.
Syrah Resources Limited (ASX:SYR)
Syrah Resources Limited, together with its subsidiaries, engages in the exploration, evaluation, and development of mineral properties in Mozambique. The company provides employment to 374 people and with the stock’s market cap sitting at AUD A$1.40B, it comes under the small-cap category.
SYR’s projected future profit growth is a robust 49.53%, with an equally impressive underlying growth from its revenues expected over the upcoming years. It appears that SYR’s profitability may be sustainable as the fundamental push is top-line expansion rather than unmaintainable cost-cutting activities. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a positive return on equity of 15.30%. SYR’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Interested to learn more about SYR? Other fundamental factors you should also consider can be found here.
Medical Developments International Limited (ASX:MVP)
Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment. The company size now stands at 53 people and with the company’s market cap sitting at AUD A$415.45M, it falls under the small-cap group.
MVP’s projected future profit growth is an exceptional 59.07%, with an underlying 89.68% growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. This prospective profitability should trickle down to shareholders, with analysts expecting the company to generate a high double-digit return on equity of 40.96%. MVP ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Should you add MVP to your portfolio? Check out its fundamental factors here.